Determination of β-blockers in pharmaceutical preparations and human urine by high-performance liquid chromatography with tris(2,2′-bipyridyl)ruthenium(II) electrogenerated chemiluminescence detection

Yu Jin Park, Dai Woon Lee, Won Yong Lee

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

A highly selective and sensitive detection method based on tris(2,2′-bipyridyl)ruthenium(II) [Ru(bpy)32+] electrogenerated chemiluminescence (ECL) has been developed for the quantitative determination of β-blockers in both pharmaceutical preparations and human urine samples. The ECL emission is based on the reaction between electro-oxidized Ru(bpy)33+ and the secondary amino groups on the β-blockers. The ECL intensities for the β-blockers were strongly dependent on the pH at which the ECL detections were conducted, with the maximum intensities being obtained at pH 9.0. Under the optimal condition, the detection limit for atenolol and metoprolol were almost 0.5μM (50pmol) and 0.08μM (8pmol), respectively, with S/N of 3 and a linear working range that extends four orders of magnitude with relative standard deviations below 5% for 10 replicate injected samples. The concentrations of atenolol and metoprolol were determined in pharmaceutical preparations using flow injection analysis with Ru(bpy)32+ ECL detection based on standard addition method. The determined values by the present method showed acceptable agreement with the stated values by manufacturers. The determination of the five β-blockers in human urine samples was performed using HPLC-Ru(bpy)32+ ECL detection. The resulting chromatogram was much simpler than that obtained with HPLC-UV absorbance detection.

Original languageEnglish
Pages (from-to)51-59
Number of pages9
JournalAnalytica Chimica Acta
Volume471
Issue number1
DOIs
Publication statusPublished - 2002 Oct 23

Fingerprint

2,2'-Dipyridyl
ruthenium
Chemiluminescence
Ruthenium
High performance liquid chromatography
Luminescence
urine
liquid chromatography
drug
High Pressure Liquid Chromatography
Urine
Pharmaceutical Preparations
Metoprolol
Atenolol
Flow Injection Analysis
detection method
absorbance
Limit of Detection
detection

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biochemistry
  • Environmental Chemistry
  • Spectroscopy

Cite this

@article{b41fb771220a42cc958e06210863c196,
title = "Determination of β-blockers in pharmaceutical preparations and human urine by high-performance liquid chromatography with tris(2,2′-bipyridyl)ruthenium(II) electrogenerated chemiluminescence detection",
abstract = "A highly selective and sensitive detection method based on tris(2,2′-bipyridyl)ruthenium(II) [Ru(bpy)32+] electrogenerated chemiluminescence (ECL) has been developed for the quantitative determination of β-blockers in both pharmaceutical preparations and human urine samples. The ECL emission is based on the reaction between electro-oxidized Ru(bpy)33+ and the secondary amino groups on the β-blockers. The ECL intensities for the β-blockers were strongly dependent on the pH at which the ECL detections were conducted, with the maximum intensities being obtained at pH 9.0. Under the optimal condition, the detection limit for atenolol and metoprolol were almost 0.5μM (50pmol) and 0.08μM (8pmol), respectively, with S/N of 3 and a linear working range that extends four orders of magnitude with relative standard deviations below 5{\%} for 10 replicate injected samples. The concentrations of atenolol and metoprolol were determined in pharmaceutical preparations using flow injection analysis with Ru(bpy)32+ ECL detection based on standard addition method. The determined values by the present method showed acceptable agreement with the stated values by manufacturers. The determination of the five β-blockers in human urine samples was performed using HPLC-Ru(bpy)32+ ECL detection. The resulting chromatogram was much simpler than that obtained with HPLC-UV absorbance detection.",
author = "Park, {Yu Jin} and Lee, {Dai Woon} and Lee, {Won Yong}",
year = "2002",
month = "10",
day = "23",
doi = "10.1016/S0003-2670(02)00932-7",
language = "English",
volume = "471",
pages = "51--59",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Determination of β-blockers in pharmaceutical preparations and human urine by high-performance liquid chromatography with tris(2,2′-bipyridyl)ruthenium(II) electrogenerated chemiluminescence detection

AU - Park, Yu Jin

AU - Lee, Dai Woon

AU - Lee, Won Yong

PY - 2002/10/23

Y1 - 2002/10/23

N2 - A highly selective and sensitive detection method based on tris(2,2′-bipyridyl)ruthenium(II) [Ru(bpy)32+] electrogenerated chemiluminescence (ECL) has been developed for the quantitative determination of β-blockers in both pharmaceutical preparations and human urine samples. The ECL emission is based on the reaction between electro-oxidized Ru(bpy)33+ and the secondary amino groups on the β-blockers. The ECL intensities for the β-blockers were strongly dependent on the pH at which the ECL detections were conducted, with the maximum intensities being obtained at pH 9.0. Under the optimal condition, the detection limit for atenolol and metoprolol were almost 0.5μM (50pmol) and 0.08μM (8pmol), respectively, with S/N of 3 and a linear working range that extends four orders of magnitude with relative standard deviations below 5% for 10 replicate injected samples. The concentrations of atenolol and metoprolol were determined in pharmaceutical preparations using flow injection analysis with Ru(bpy)32+ ECL detection based on standard addition method. The determined values by the present method showed acceptable agreement with the stated values by manufacturers. The determination of the five β-blockers in human urine samples was performed using HPLC-Ru(bpy)32+ ECL detection. The resulting chromatogram was much simpler than that obtained with HPLC-UV absorbance detection.

AB - A highly selective and sensitive detection method based on tris(2,2′-bipyridyl)ruthenium(II) [Ru(bpy)32+] electrogenerated chemiluminescence (ECL) has been developed for the quantitative determination of β-blockers in both pharmaceutical preparations and human urine samples. The ECL emission is based on the reaction between electro-oxidized Ru(bpy)33+ and the secondary amino groups on the β-blockers. The ECL intensities for the β-blockers were strongly dependent on the pH at which the ECL detections were conducted, with the maximum intensities being obtained at pH 9.0. Under the optimal condition, the detection limit for atenolol and metoprolol were almost 0.5μM (50pmol) and 0.08μM (8pmol), respectively, with S/N of 3 and a linear working range that extends four orders of magnitude with relative standard deviations below 5% for 10 replicate injected samples. The concentrations of atenolol and metoprolol were determined in pharmaceutical preparations using flow injection analysis with Ru(bpy)32+ ECL detection based on standard addition method. The determined values by the present method showed acceptable agreement with the stated values by manufacturers. The determination of the five β-blockers in human urine samples was performed using HPLC-Ru(bpy)32+ ECL detection. The resulting chromatogram was much simpler than that obtained with HPLC-UV absorbance detection.

UR - http://www.scopus.com/inward/record.url?scp=0037164177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037164177&partnerID=8YFLogxK

U2 - 10.1016/S0003-2670(02)00932-7

DO - 10.1016/S0003-2670(02)00932-7

M3 - Article

AN - SCOPUS:0037164177

VL - 471

SP - 51

EP - 59

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

IS - 1

ER -